Showing results (1181-1190 of 2,993) with videos related to
Sort By:
Pageof 300
Seminars in Thrombosis and Hemostasis|September 9, 2005
Investigation of the PADA as a method for monitoring GPIIb/IIIa inhibitors and other antiplatelet agentsJochen Graff, Sebastian HarderSeminars in Thrombosis and Hemostasis|July 30, 2005
Severe gastrointestinal bleeding during pregnancy in a case of blue rubber bleb nevus syndromeMakoto Kanai, Masami Noike, Chiho Masaki, et al.Seminars in Thrombosis and Hemostasis|July 30, 2005
Changes in antithrombin activity and platelet counts in the late stage of twin and triplet pregnanciesMamoru Morikawa, Takashi Yamada, Soromon Kataoka, et al.Seminars in Thrombosis and Hemostasis|July 30, 2005
Phosphatidylserine/phosphatidylcholine microvesicles can induce preeclampsia-like changes in pregnant miceKohei Omatsu, Takao Kobayashi, Yusuke Murakami, et al.Seminars in Thrombosis and Hemostasis|July 30, 2005
Des-gamma-carboxyprothrombin (PIVKA-II) levels in maternal serum throughout gestationTomizo Nishiguchi, Kaoru Matsuyama, Takao Kobayashi, et al.Seminars in Thrombosis and Hemostasis|April 27, 2005
Pharmacology of CS-747 (prasugrel, LY640315), a novel, potent antiplatelet agent with in vivo P2Y12 receptor antagonist activityYoichi Niitsu, Joseph A Jakubowski, Atsuhiro Sugidachi, et al.Seminars in Thrombosis and Hemostasis|July 1, 2006
The impact of clinicopathological studies on staging and survival in essential thrombocythemia, chronic idiopathic myelofibrosis, and polycythemia rubra veraHans Michael Kvasnicka, Juergen ThieleSeminars in Thrombosis and Hemostasis|July 1, 2006
Anagrelide: what was new in 2004 and 2005?Petro E PetridesSeminars in Thrombosis and Hemostasis|July 1, 2006
Long-term incidence of hematological evolution in three French prospective studies of hydroxyurea and pipobroman in polycythemia vera and essential thrombocythemiaJean-Jacques Kiladjian, Jean-Didier Rain, Jean-Francois Bernard, et al.Seminars in Thrombosis and Hemostasis|January 1, 1994
Hemostatic system activation in patients with lupus anticoagulant and essential thrombocythemiaA Falanga, F A Ofosu, S Cortelazzo, et al.Pageof 300